Reduction of ectopic bone growth in critically-sized rat mandible defects by delivery of rhBMP-2 from kerateine biomaterials

Biomaterials

Volumn 35, Issue 10, 2014, Pages 3220-3228

  Kowalczewski, Christine J ^a,b   Tombyln, Seth ^c   Wasnick, David C ^a   Hughes, Michael R ^a   Ellenburg, Mary D ^c   Callahan, Michael F ^d   Smith, Thomas L ^e   Van Dyke, Mark E ^b   Burnett, Luke R ^c   Saul, Justin M ^a  

^a MIAMI UNIVERSITY   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c KeraNetics LLC   (United States)

^d MU Life Sciences Business Incubator at Monsanto Place   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Bone regeneration; Collagen; Hydrogel; In vivo test; Keratin; Scaffold

Indexed keywords

BONE MINERAL DENSITY; BONE REGENERATION; HUMAN BONE MORPHOGENETIC PROTEIN; IN-VIVO TESTS; MANDIBULAR DEFECT; MICROCOMPUTED TOMOGRAPHY; REGENERATIVE CAPACITY; THERAPEUTIC AGENTS;

BIOLOGICAL MATERIALS; BONE; COLLAGEN; COMPUTERIZED TOMOGRAPHY; DEFECTS; KERATIN; RATS; SCAFFOLDS;

HYDROGELS;

COLLAGEN SPONGE; KERATIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE GROWTH; BONE REGENERATION; ECTOPIC BONE GROWTH; HYDROGEL; IN VIVO STUDY; JAW MALFORMATION; MALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT;

ANIMALIA; RATTUS;

BONE REGENERATION; COLLAGEN; HYDROGEL; IN VIVO TEST; KERATIN; SCAFFOLD;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; KERATINS; MALE; MANDIBLE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; RHEOLOGY; TISSUE SCAFFOLDS;

EID: 84893685031     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.12.087     Document Type: Article

References (33)

1. Katzen J.T., Jarrahy R., Eby J., Mathiasen R., Margulies D., Shahinian H. Craniofacial and skull base trauma. J Trauma Injury Infect Crit Care 2003, 54:1026-1034.
2. Lew T.A., Walker J.A., Wenke J.C., Blackbourne L.H., Hale R.G. Characterization of craniomaxillofacial battle injuries sustained by United States service members in the current conflicts of Iraq and Afghanistan. J Oral Maxillofac Surg 2010, 68:3-7.
3. Salinas N.L., Brennan J., Gibbons M.D. Massive facial trauma following improvised explosive device blasts in Operation Iraqi Freedom. Otolaryngol Head Neck Surg 2011, 144:703-707.
4. American Society of Plastic Surgeons: 2012 Plastic surgery procedural statistics 2013, Online, Available from: URL:. http://www.plasticsurgery.org/Documents/news-resources/statistics/2012-Plastic-Surgery-Statistics/Cosmetic-Procedure-Trends-2012.pdf.
5. Cutter C.S., Mehrara B.J. Bone grafts and substitutes. J Long Term Eff Med Implants 2006, 16:249-260.
6. Wegman F., Geuze R.E., Van Der Helm YJ., Öner F.C., Dhert W.J.A., Alblas J. Gene delivery of bone morphogenetic protein-2 plasmid DNA promotes bone formation in a large animal model. J Tissue Eng Regen Med 2012 August, Online, Available from: URL:. http://onlinelibrary.wiley.com/doi/10.1002/term.1571/abstract.
7. ® Bone Graft). Int Orthop 2007, 2:729-734.
8. Bosch P., Musgrave D., Lee J.Y., Cummins J., Shuler F., Ghivizzani S., et al. Osteoprogenitor cells in skeletal muscle. J Orthop Res 1999, 18:933-944.
9. Chappuis V., Gamer L., Cox K., Lowery J.W., Bosshardt D.D., Rosen V. Periosteal BMP2 activity drives bone graft healing. Bone 2012, 51:800-809.
10. Kempen D.H.R., Lu L., Hefferan T.E., Creemers L.B., Maran A., Classic K.L., et al. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 2008, 29:3245-3252.
11. Woo E.J. Adverse events reported after the use of recombinant human bone morphogenetic protein 2. J Oral Maxillofac Surg 2012, 70:765-767.
12. Ratner B.D., Hoffman A.S., Schoen F.J., Lemons J.E. Biomaterials science: an introduction to materials in medicine 2012, Elsevier Inc., Walham, MA. 3rd ed.
13. Kumar R., Balaji S., Uma T.S., Mandal A.B., Sehgal P.K. Optimization of influential parameters for extracellular keratinase production by Bacillus subtilis (MTCC9102) in solid state fermentation using horn meal - a biowaste management. Appl Biochem Biotechnol 2010, 160:30-39.
14. Anitha T.S., Palanivelu P. Purification and characterization of an extracellular keratinolytic protease from a new isolate of Aspergillus parasiticus. Protein Expr Purif 2013, 88:214-220.
15. Rouse J.G., Van Dyke M.E. A review of keratin-based biomaterials for biomedical applications. Materials 2010, 3:999-1014.
16. de Guzman R.C., Merrill M.R., Richter J.R., Hamzi R.I., Greengauz-Roberts O.K., Van Dyke M.E. Biomaterials mechanical and biological properties of keratose biomaterials. Biomaterials 2011, 32:8205-8217.
17. Hill P., Brantley H., Van Dyke M. Some properties of keratin biomaterials: kerateines. Biomaterials 2010, 31:585-593.
18. Koehn H., Clerens S., Deb-Choudhury S., Morton J.D., Dyer J.M., Plowman J.E. The proteome of the wool cuticle. J Proteome Res 2010, 2920-2928.
19. Plowman J.E. The proteomics of keratin proteins. J Chromatogr 2007, 849:181-189.
20. Crewther W.G., Fraser D.B., Lennox F.G., Lindley H. Advances in protein chemistry 1965, vol. 20:191-347. Academic Press, New York, NY.
21. Saul J.M., Ellenburg M.D., de Guzman R.C., Van Dyke M. Keratin hydrogels support the sustained release of bioactive ciprofloxacin. J Biomed Mater Res A 2011, 98:544-553.
22. de Guzman R.C., Saul J.M., Ellenburg M.D., Merrill M.R., Coan H.B., Smith T.L., et al. Bone regeneration with BMP-2 delivered from keratose scaffolds. Biomaterials 2013, 34:1644-1656.
23. Uludag Hasan, Gao T. Delivery systems for BMPs: factors contributing to protein retention at an application site. J Bone Jt Surg 2001, 83-A.
24. Luca L., Rougemont A.-L., Walpoth B.H., Gurny R., Jordan O. The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formation. J Control Release 2010, 147:38-44.
25. Zhang Z., Li G., Shi B.I., Key T., Chemistry L. Physicochemical properties of collagen, gelatin and collagen hydrolysate derived from bovine limed split wastes. J Soc Leath Tech Ch 2005, 90:23-28.
26. Friess W., Uludag H., Foskett S., Biron R., Sargeant C. Characterization of absorbable collagen sponges as rhBMP-2 carriers. Int J Pharm 1999, 187:91-99.
27. Gorham S.D., Hyland T.P., French D.A., Willins M.J. Cellular invasion and breakdown of three different collagen films in the lumbar muscle of the rat. Biomaterials 1990, 11:113-118.
28. Arosarena O., Collins W. Comparison of BMP-2 and -4 for rat mandibular bone regeneration at various doses 1. Orthod Craniofac Res 2005, 8:267-276.
29. Wen B., Karl M., Pendrys D., Shafer D., Freilich M., Kuhn L. An evaluation of BMP-2 delivery from scaffolds with miniaturized dental implants in a novel rat mandible model. J Biomed Mater Res Part B 2011, 97B:315-326.
30. Brown K.V., Lon M., Li B., Ph D., Guda T., Perrien D.S., et al. Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release. Tissue Eng Part A 2011, 17:1735-1746.
31. Vaibhav B., Nilesh P., Vikram S., Anshul C. Bone morphogenic protein and its application in trauma cases: a current concept update. Injury 2007, 38:1227-1235.
32. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994, 127:1755-1766.
33. Puleo D.A. Dependence of mesenchymal cell responses on duration of exposure to bone morphogenetic protein-2 in vitro. J Cell Physiol 1997, 173:93-101.